医学
加药
糖尿病
肾功能
重症监护医学
肾脏疾病
血糖性
疾病
肾
药理学
内科学
内分泌学
作者
James Reilly,Jeffrey S. Berns
标识
DOI:10.1111/j.1525-139x.2010.00703.x
摘要
Abstract Diabetes mellitus is a leading cause of kidney disease worldwide. A large and expanding array of treatments for diabetes is available to improve glycemic control, including newer classes of drugs, such as thiazolidinediones and incretin‐based therapies. The presence of impaired kidney function with reduced glomerular filtration rate should influence choices, dosing, and monitoring of hypoglycemic agents, as some agents require a dosing adjustment in patients with kidney disease and some are entirely contraindicated. This article reviews the clinical use of insulin and other antidiabetic therapies, focusing on pharmacokinetic properties and dosing in patients with advanced kidney disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI